Silicon-Driven Health: AI Digital Twins And The US$1 Billion Pharma Deal
As massive capital flows into the life science sector, two distinct, and potentially opposing, strategic directions have emerged. While NVIDIA (NASDAQ:NVDA) is expanding its healthcare presence through a US$1 billion deal with Eli Lilly and Company (NYSE:LLY), Twin Health’s metabolic AI uses digital twins alongside device-driven biometrics to reverse chronic disease, a shift with the
